Bommarius Andreas S
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30318; email:
Annu Rev Chem Biomol Eng. 2015;6:319-45. doi: 10.1146/annurev-chembioeng-061114-123415.
This review describes the status of the fields of biocatalysts and enzymes, as well as existing drawbacks, and recent advances in the areas deemed to represent drawbacks. Although biocatalysts are often highly active and extremely selective, there are still drawbacks associated with biocatalysis as a generally applicable technique: the lack of designability of biocatalysts; their limits of stability; and the insufficient number of well-characterized, ready-to-use biocatalysts. There has been significant progress on the following fronts: (a) novel protein engineering tools, both experimental and computational, have significantly enhanced the toolbox for biocatalyst development. (b) The deactivation of biocatalysts under various stresses can be described quantitatively via rational models. There are several cases of spectacular leaps of stabilization after accumulating all stabilizing mutations found in earlier rounds. The concept that stabilization against one type of stress commonly also stabilizes against other types of stress is now experimentally considerably better founded than a few years ago.
本综述描述了生物催化剂和酶领域的现状、存在的缺点以及在被视为缺点的领域中的最新进展。尽管生物催化剂通常具有高活性和极高的选择性,但作为一种普遍适用的技术,生物催化仍存在一些缺点:生物催化剂缺乏可设计性;其稳定性有限;以及经过充分表征、可直接使用的生物催化剂数量不足。在以下几个方面取得了重大进展:(a)新型蛋白质工程工具,包括实验性和计算性工具,显著增强了生物催化剂开发的工具库。(b) 可以通过合理的模型定量描述生物催化剂在各种应力下的失活情况。在积累了早期轮次中发现的所有稳定突变后,有几例实现了显著的稳定性提升。与几年前相比,现在实验上有了更好的依据来证明针对一种类型的应力进行稳定化通常也能针对其他类型的应力实现稳定化这一概念。